Medical Procedures
Explore procedure pages with patient-friendly context about preparation, expectations, and recovery.
All medical procedures (122,362)
Diagnostic
pre-beta-Lipoprotein measurement
pre-beta-Lipoprotein measurement — clinical procedure (SNOMED CT 104788009).
Other
predniSONE [Mass/time] in 24 hour Urine
Other
predniSONE [Mass/volume] in Urine
Other
predniSONE [Measurement] in Urine
Other
predniSONE [Moles/volume] in Urine
Other
prednisoLONE [Mass/volume] in Urine
Other
prednisoLONE [Moles/volume] in Urine
Other
prescription First glasses
Other
prescription Glasses type
Other
prescription Glasses type [Text]
Other
quiNIDine [Mass/volume] in Body fluid
Other
quiNIDine [Mass/volume] in Urine
Other
quiNIDine [Mass] of Dose
Other
quiNIDine [Presence] in Specimen
Other
quiNIDine [Presence] in Urine
Other
quiNIDine+Quinine [Presence] in Urine
Other
quiNINE [Mass/volume] in Urine
Other
quiNINE [Mass] of Dose
Other
quiNINE [Measurement] in Urine
Other
quiNINE [Moles/volume] in Gastric fluid
Other
quiNINE [Moles/volume] in Specimen
Other
quiNINE [Moles/volume] in Urine
Other
quiNINE [Presence] in Gastric fluid
Other
quiNINE [Presence] in Specimen
Other
quiNINE [Presence] in Urine
Other
raNITIdine [Presence] in Gastric fluid
Other
raNITIdine [Presence] in Specimen
Other
raNITIdine [Presence] in Urine
Other
rifAMPin [Mass/volume] in DBS
Other
rifAMPin [Mass] of Dose
Other
rifAMPin [Susceptibility]
Other
rifAMPin [Susceptibility] by Disk diffusion (KB)
Other
rifAMPin [Susceptibility] by Genotype method
Other
rifAMPin [Susceptibility] by Gradient strip
Other
rifAMPin [Susceptibility] by Method for Slow-growing mycobacteria
Other
rifAMPin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 1.0 ug/mL
Other
rifAMPin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 14.0 ug/mL
Other
rifAMPin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 2.0 ug/mL
Other
rifAMPin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 40.0 ug/mL
Other
rifAMPin [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 5.0 ug/mL
Other
rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC)
Other
rifAMPin [Susceptibility] by Minimum lethal concentration (MLC)
Other
rifAMPin [Susceptibility] by Serum bactericidal titer
Other
rifAXIMin [Susceptibility]
Other
rifAXIMin [Susceptibility] by Disk diffusion (KB)
Other
rifAXIMin [Susceptibility] by Minimum inhibitory concentration (MIC)
Other
risperiDONE [Mass/volume] in Urine by Confirmatory method
Other
risperiDONE [Presence] in Specimen
Other
risperiDONE [Presence] in Urine
Other
risperiDONE cutoff [Mass/volume] in Urine for Confirmatory method
Diagnostic
sec-Butyl acetate measurement
sec-Butyl acetate measurement — clinical procedure (SNOMED CT 121683003).
Other
ssDNA binding autoantibody level
ssDNA binding autoantibody level — clinical procedure (SNOMED CT 143308000).
Other
ssDNA binding autoantibody level
ssDNA binding autoantibody level — clinical procedure (SNOMED CT 165922000).
Other
sulfADIAZINE [Mass/volume] in Urine
Other
sulfADIAZINE [Mass] of Dose
Other
sulfADIAZINE [Susceptibility]
Other
sulfADIAZINE [Susceptibility] by Disk diffusion (KB)
Other
sulfADIAZINE [Susceptibility] by Gradient strip
Other
sulfADIAZINE [Susceptibility] by Minimum inhibitory concentration (MIC)
Other
sulfADIAZINE [Susceptibility] by Minimum lethal concentration (MLC)
Other
sulfADIAZINE [Susceptibility] by Serum bactericidal titer
Other
sulfiSOXAZOLE [Mass] of Dose
Other
sulfiSOXAZOLE [Susceptibility]
Other
sulfiSOXAZOLE [Susceptibility] by Disk diffusion (KB)
Other
sulfiSOXAZOLE [Susceptibility] by Gradient strip
Other
sulfiSOXAZOLE [Susceptibility] by Method for Slow-growing mycobacteria.antibiotic concentration at 300.0 ug/mL
Other
sulfiSOXAZOLE [Susceptibility] by Minimum inhibitory concentration (MIC)
Other
sulfiSOXAZOLE [Susceptibility] by Minimum lethal concentration (MLC)
Other
sulfiSOXAZOLE [Susceptibility] by Serum bactericidal titer
Other
t(11;14)(q13;q32)(CCND1,IGH) fusion transcript [Presence] in Bone marrow by Molecular genetics method
Other
t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript [Presence] in Bone marrow by Molecular genetics method
Other
t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
Other
t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript major break points [Presence] in Bone marrow by Molecular genetics method
Other
t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript major break points [Presence] in Cerebral spinal fluid by Molecular genetics method
Other
t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript minor break points [Presence] in Bone marrow by Molecular genetics method
Other
t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript minor break points [Presence] in Cerebral spinal fluid by Molecular genetics method
Other
t(15;17)(q24.1;q21.1)(PML,RARA) bcr1 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
Other
t(15;17)(q24.1;q21.1)(PML,RARA) bcr2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
Other
t(15;17)(q24.1;q21.1)(PML,RARA) bcr3 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
Other
t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript [Presence] in Bone marrow by Molecular genetics method
Other
t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
Other
t(1;13)(p36.13;q14.1)(PAX7,FOXO1) and t(2;13)(q36.1;q14.4)(PAX3,FOXO1) fusion transcript in Bone marrow by Molecular genetics method
Other
t(2;3)(q13;p25)(PAX8,PPARG) fusion transcript [Presence] in Tissue by Molecular genetics method
Other
t(4;11)(q21.3;q23)(AFF1,MLL) fusion transcript [Presence] in Bone marrow by Molecular genetics method
Other
t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript [Presence] in Bone marrow by Molecular genetics method
Other
t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
Other
t(9;12)(q34.1;p13)(ABL1,ETV6) fusion transcript [Presence] in Bone marrow by Molecular genetics method
Other
t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript [Presence] in Bone marrow by Molecular genetics method
Other
t(9;22)(q34.1;q11)(ABL1,BCR) b3a2 fusion transcript [Presence] in Bone marrow by Molecular genetics method
Other
t(9;22)(q34.1;q11)(ABL1,BCR) e19a2 fusion transcript [Presence] in Bone marrow by Molecular genetics method
Other
t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript [Presence] in Bone marrow by Molecular genetics method
Other
t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
Other
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript [Presence] in Bone marrow by Molecular genetics method
Other
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript in Bone marrow by Molecular genetics method
Other
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript/control transcript [Log Number Ratio] in Bone marrow by Molecular genetics method
Other
t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript/control transcript [Log Number Ratio] in Specimen by Molecular genetics method
Diagnostic
tPA-PAI complex assay
tPA-PAI complex assay — clinical procedure (SNOMED CT 103834001).
Diagnostic
tert-Butyl alcohol measurement
tert-Butyl alcohol measurement — clinical procedure (SNOMED CT 121883000).
Other
tiZANidine/Creatinine [Mass Ratio] in Urine by Confirmatory method
Other
tiaGABine/Creatinine [Mass Ratio] in Urine by Confirmatory method